共 50 条
- [21] Evidence for Cardiorenal Protection with SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Patients with Diabetic Kidney Disease JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (02):
- [26] Mineralocorticoid Receptor Antagonists in the Treatment of Diabetic Kidney Disease: Their Application in the Era of SGLT2 Inhibitors and GLP-1 Receptor Agonists Current Diabetes Reports, 2022, 22 : 213 - 218
- [29] The Impact of GLP-1 Receptor Agonists on Bowel Preparation for Colonoscopy AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S600 - S600